arXiv:2506. 10912v4 Announce Type: replace Abstract: Toxicity remains a leading cause of early-stage drug development failure.
By Fei Lin, Ziyang Gong, Cong Wang, Tengchao Zhang, Yonglin Tian, Yining Jiang, Ji Dai, Chao Guo, Xiaotong Yu, Xue Yang, Gen Luo, Fei-Yue Wang
The paper introduces HarmReduction, a benchmark for evaluating large language models (LLMs) on their ability to provide accurate and safe harm reduction information to people who use drugs (PWUD). The benchmark, HR-Basic, contains 2,160 question‑answer‑evidence pairs covering safety boundary checks, quantitative value provision, and polysubstance risk inference. Experiments show that even state‑of‑the‑art LLMs struggle with accuracy and can pose severe safety risks, underscoring the need for a dedicated evaluation framework.
By Kaixuan Wang, Chenxin Diao, Jason T. Jacques, Zhongliang Guo, Shuai Zhao
The paper introduces DeToxR, a reinforcement‑learning‑enhanced large language model designed to support decision making in acute toxicology cases. It fuses unstructured narratives from paramedics and patients with structured vital‑sign data to predict co‑ingested substances across 14 classes. In preliminary validation, DeToxR outperforms baseline models, achieving higher micro‑F1 and recall scores for poison identification.
By Nico Oberl\"ander, David Bani-Harouni, Tobias Zellner, Nassir Navab, Florian Eyer, Matthias Keicher
arXiv:2607. 12886v1 Announce Type: new Abstract: Clinical notes contain many of the signs and symptoms that bring patients to care, yet this information rarely reaches structured fields.
By Cameron Cagan, Pedram Fard, Jiazi Tian, Jingya Cheng, Shawn N. Murphy, Hossein Estiri
The paper introduces a framework to predict whether a compound’s potency can be quantified in dose‑response profiling, treating quantifiability as a separate triage goal from biological activity. It shows that features from low‑cost primary screens, rather than molecular structure, strongly predict quantifiability, and that this prediction holds across new chemical scaffolds and assay families. The authors argue that incorporating quantifiability predictions can better allocate expensive dose‑response resources.
By Sean Lim
arXiv:2609.21859v1 Announce Type: new
Abstract: Nearly 90% of drugs entering clinical development ultimately fail, despite billions of dollars in investment. Pharmaceutical companies therefore rely o...
By Jiacheng Lin, Zifeng Wang, Zheng Chen, Erick Scott, Ziwei Yang, Fanyang Yu, Sheng Zhong, Jimeng Sun